Search results
Pfizer to Cut Costs in Multi-Year Effort
The Wall Street Journal· 4 days agoThe company said it estimates savings of $1.5 billion in the plan’s first phase by the end of 2027.
Pfizer announces another $1.5B in cost cuts — and plans for more to come
Endpoints News· 4 days agoMonths after beginning a $4 billion savings strategy, Pfizer is planning on a new $1.5 billion round...
This Stock Has Gained 150% Since I Bought It – but It Could Still Be a Bargain
Motley Fool via Yahoo Finance· 1 hour agoStrong business results To be fair, quite a bit of Wells Fargo's tremendous performance occurred...
Sen. Wyden questions Pfizer over tax rate as part of ongoing investigation
Endpoints News· 5 days agoSenate Finance Chair Ron Wyden (D-OR) is pressing Pfizer over its tax practices as part of his investigation into how large pharma companies use subsidiaries in other countries ...
Pfizer's $1.5B cuts; Biogen's $1.15B buyout; AstraZeneca's $80B ambition; RNA startup merger; and...
Endpoints News· 1 day agoWant this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. Whether you will be in San Diego for BIO, we hope you will join ...
1 High-Yield ETF Could Turn $400 Per Month Into $50,000 In Annual Dividend Income
Motley Fool via Yahoo Finance· 3 hours agoDividend Equity ETF are: Texas Instruments (2.6% dividend yield) Amgen (2.9%) Lockheed Martin (2.7%)...
Vaccine stocks gain, Moderna and Pfizer in talks with the US on bird flu vaccines By Investing.com
Investing.com· 3 days agoVaccine stocks gain, Moderna and Pfizer in talks with the US on bird flu vaccines
Is Pfizer Finally Seeing Light at the End of the Tunnel?
TheStreet.com· 3 days agoPharmaceutical giant Pfizer (PFE) has been a weak performer in the stock market. The shares are...
AstraZeneca sets sights on $80B in revenue by 2030
BioPharma Dive via Yahoo Finance· 5 days agoA decade ago, as British drugmaker AstraZeneca fought off a hostile takeover bid by Pfizer, CEO Pascal Soriot made a big promise: The company, he said,...
GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims
Benzinga via Yahoo Finance· 5 days agoRelated: Pfizer Agrees To Settle Over 10,000 Lawsuits About Cancer Risks Associated With...